WhiteSwell
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1900 S Norfolk St Ste 350, San Mateo, Ca...Website
www.whiteswell.comRevenue
<$5 MillionIndustry
About WhiteSwell
WhiteSwell Org Chart
Is WhiteSwell your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if WhiteSwell is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if WhiteSwell had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at WhiteSwell
Product Launch: Get notified when WhiteSwell launches new products
Check if WhiteSwell has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
WhiteSwell, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once WhiteSwell has new funding data
Earning: See what the market has to say on WhiteSwell recently announced quarterly report
Recommended Actions
Find VP level buyers at WhiteSwell
Find 2 more new buyers
Compare Similar Companies to WhiteSwell
Compare insights from companies similar to WhiteSwell, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
WhiteSwell is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
WhiteSwell is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about WhiteSwell.
WhiteSwell financials insights
Gather financial insights about WhiteSwell, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series B
$30M
WhiteSwell Tech Stack
A closer look at the technologies used by WhiteSwell
Most Recent Scoops
WhiteSwell News & Media
WhiteSwell Announces New Data Supporting Acute Decompensated Heart Failure Treatment with eLym System
GALWAY, Ireland--(BUSINESS WIRE)--WhiteSwell, a company pioneering a new paradigm in the treatment of acute decompensated heart failure (ADHF), announced today positive data from 21 patients treated in its DELTA-HF trial evaluating the WhiteSwell eLym™ System. The data were presented at the Technology and Heart Failure Therapeutics (THT) meeting in Boston by Jan Biegus, M.D., deputy scientific director at the Institute of Heart Diseases at Wroclaw Medical University in Poland. “Persistent congeWhiteSwell Expands Leadership Team with Key Appointments
GALWAY, Ireland--(BUSINESS WIRE)--WhiteSwell, a company pioneering a new paradigm in the treatment of acute decompensated heart failure (ADHF), today announced the appointments of Ric Cote to its board of directors and Sergio Shkurovich as vice president of clinical affairs. Ric Cote brings over three decades of experience in the medical device industry to the board. He is currently the CEO of Channel Medsystems, where he leads a team committed to empowering women to take controlWhiteSwell Announces Six-month Outcomes After eLym System Treatment for Acute Decompensated Heart Failure Patients in its DELTA-HF Study
GALWAY, Ireland--(BUSINESS WIRE)--WhiteSwell, a company pioneering a new paradigm in the treatment of acute decompensated heart failure (ADHF), announced today positive six-month follow-up data on the initial nine patients treated in its ongoing DELTA-HF trial evaluating the WhiteSwell eLym™ System. The data were presented by William Abraham, M.D., professor of medicine, physiology, and cell biology at The Ohio State University Wexner Medical Center, at the Technology and Heart Failure TherapeuWhiteSwell Announces Successful Treatment of Acute Decompensated Heart Failure Patients in its Early Feasibility DELTA-HF Study
GALWAY, Ireland--(BUSINESS WIRE)--WhiteSwell, a company pioneering a new paradigm in the treatment of acute decompensated heart failure (ADHF), announced today positive initial results from its ongoing DELTA-HF trial evaluating the WhiteSwell eLym™ System. The data were presented at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2023 in Cleveland, Ohio. In DELTA-HF, a minimally invasive catheter-based system is introduced to facilitate the removal of excess fluid from the
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding WhiteSwell
WhiteSwell is a patient-focused company dedicated to treating acute decompensated heart failure (ADHF) by enhancing the body's lymphatic system to aid in decongestion. Their innovative eLym System is designed to reduce resistance at the thoracic duct outlet, facilitating better lymphatic drainage and addressing tissue congestion. The company aims t... Read More